Quanta Capital Holdings Ltd (QNTA) – PRNewswire
-
Medolife Rx, Inc. Has Submitted Applications Of Their Scorpion Venom To Help Fight Against Cancer And COVID-19 With The FDA In The Dominican Republic; The FDA Is In The Process Of Investigation And C
-
Quanta Announces Acquisition of 51% of Medolife Rx
-
Quanta Shareholder Update
-
Quanta Announces "Town Hall" Style Shareholder Update for May 21, 2020 at 1:30 PM ET
-
Quanta Names Francisco Ortiz as Head of Sales
-
Quanta Announces Significant Advancements in ATP Production with Polarization Technology Platform
-
Quanta, Inc. Announces the Addition of Eddy Pham to Advisory Board
-
Quanta Announces Full Year 2019 Results
-
Quanta Announces Distribution Agreement with Hanson Faso Sales & Marketing, Inc.
-
A Quantum Union: Quanta, Inc & RST-Sanexas Announce Partnership
-
Quanta, Inc. Announces $6.1M Raise -- Connecticut-Based Southridge Leads Group Investment in Applied Science Products Producer
-
Quanta Announces Successful Q2 Sales Growth of Flagship Polarized Products
-
Quanta Partners with Influential Pharmacy Distribution and Marketing Company PharmaLynk
Back to QNTA Stock Lookup